Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY11.85 CNY
Change Today +0.26 / 2.24%
Volume 76.7M
600664 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

harbin pharmaceutical grp-a (600664) Snapshot

Open
CNY11.65
Previous Close
CNY11.59
Day High
CNY11.99
Day Low
CNY11.49
52 Week High
04/14/15 - CNY12.28
52 Week Low
05/23/14 - CNY5.97
Market Cap
22.7B
Average Volume 10 Days
60.4M
EPS TTM
CNY0.12
Shares Outstanding
1.9B
EX-Date
08/26/15
P/E TM
99.1x
Dividend
--
Dividend Yield
0.56%
Current Stock Chart for HARBIN PHARMACEUTICAL GRP-A (600664)

Related News

No related news articles were found.

harbin pharmaceutical grp-a (600664) Related Businessweek News

No Related Businessweek News Found

harbin pharmaceutical grp-a (600664) Details

Harbin Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and trading of pharmaceutical in China and internationally. The company offers antibiotics, small-molecular drug preparations, OTC and healthcare products, modern Chinese medicines, biopharmaceuticals, animal vaccines, and medicine circulations under the Hongyan Yaopin, Guangwei, Renmin Tongtai, Hayao Shengwu, Baohulu, Manshanhong, Hutong, Hayaoliu, Gaizhonggai, Sanchine, Shiyitang, and Hayao brands. Its APIs include penicillin, cephalosporin, and intermediates. Harbin Pharmaceutical Group Co., Ltd. is based in Harbin, China.

harbin pharmaceutical grp-a (600664) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

harbin pharmaceutical grp-a (600664) Key Developments

Harbin Pharmaceutical Group Co., Ltd. to Report Q1, 2015 Results on Apr 30, 2015

Harbin Pharmaceutical Group Co., Ltd. announced that they will report Q1, 2015 results on Apr 30, 2015

Harbin Pharmaceutical Group Co., Ltd. Announces Earnings Results for the First Quarter of 2015

Harbin Pharmaceutical Group Co., Ltd. announced earnings results for the first quarter of 2015. For the quarter the company reported basic earnings per share CNY 0.08 and weighted average return on net assets 1.93%.

Harbin Pharmaceutical Group Co., Ltd., Annual General Meeting, Mar 12, 2015

Harbin Pharmaceutical Group Co., Ltd., Annual General Meeting, Mar 12, 2015., at 09:00 China Standard Time. Agenda: To discuss issues including the proposal of full text of annual report of 2014 and its abstract; to consider the scheme on annual profit distribution scheme for 2014; to consider the proposal of sum-up report on audit work of accounting firm in 2014; and to consider the renewing engagement of its accounting firm.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600664:CH CNY11.85 CNY +0.26

600664 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China BCT Pharmacy Group Inc $0.02 USD -0.005
Kirin Holdings Co Ltd ¥1,766 JPY -14.00
Roche Holding AG SFr.277.90 CHF -1.30
View Industry Companies
 

Industry Analysis

600664

Industry Average

Valuation 600664 Industry Range
Price/Earnings 96.2x
Price/Sales 1.5x
Price/Book 2.9x
Price/Cash Flow 95.5x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HARBIN PHARMACEUTICAL GRP-A, please visit www.hayao.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.